In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
484 News Items found
Linda Collins, an MSK patient, posing for a photo outside
Why Black Women Are Twice as Likely to Die of Endometrial Cancer — and What MSK Is Doing to Change It

Learn why Black women face a higher risk of death from endometrial cancer, and about a new effort led by Dr. Carol Brown at Memorial Sloan Kettering Cancer Center to close the gap.
Andrea Barrio, a breast cancer surgeon at Memorial Sloan Kettering Cancer Center, talks to a patient
Important New Insights into Lymphedema: High Risk, Race, and Ethnicity

Learn about research on lymphedema at Memorial Sloan Kettering Cancer Center, which finds that Black and Hispanic women are at highest risk.
Christopher Klebanoff
In the Lab
New Immunotherapy Approach Targets a Commonly Mutated ‘Driver’ Protein Unique to Cancer Cells

Investigators at MSK are developing new immunotherapy treatments that rely on engineering T cells to recognize mutated proteins that are unique to cancer.
MSK director of social work Penny Damaskos, posing with a human-sized number 8
Feature
How Social Workers Help People with Cancer: 8 Questions with Penny Damaskos

Meet MSK Director of Social Work Penny Damaskos and learn how she and her team help people with cancer.
Claire’s Legacy
MSK Giving: Claire’s Legacy

Learn why an MSK patient is supporting the MSK mission with a bequest.
Alicia Kalogeropoulos with her husband, Alex, at the beach.
Feature
Top Cancer Treatment Advances at MSK in 2023

Doctors at Memorial Sloan Kettering Cancer Center (MSK) pioneered advances in many types of cancer treatment for patients in 2023. Read about some of the most important developments over the past year.
detail shot of a lab coat with the MSK logo
MSK Research Highlights, June 18, 2025

New MSK research finds improving intestinal metabolism may help treat chronic inflammation and prevent cancer; shows how breast cancer resistance is linked to APOBEC3 enzymes; investigates opportunities for restoring sensitivity to endocrine therapy; and finds acupuncture may help prostate cancer survivors wake up less often at night to urinate.
MSK bile duct cancer patient Berta Pesantez
How MSK Is Making Cancer Clinical Trials in NYC Easier To Access

For many patients, time is of the essence. At MSK, patients have access to potentially lifesaving therapies long before they are available at community hospitals. Learn how MSK’s Cancer Health Equity Research Program (CHERP) partners with a network of public hospitals in New York City to recruit underserved patients for clinical trials at MSK and give them access to world-class care.
John Mendelsohn
Feature
Remembering John Mendelsohn, a Pioneer of Targeted Therapy for Cancer

The scientific world lost one of its greats this week. Here, we reflect on his influence.
Woman giving presentation at work
Finding
Study Highlights Workplace Difficulties Some Women Face During Cancer Treatment

Discover the role of the work environment in the life and career of an employee with cancer.